AbbVie (ABBV) stock CFD trading.

Trading under the ticker ABBV on the NYSE, AbbVie is a biopharmaceutical company best known for Humira and its successor immunology drugs Skyrizi and Rinvoq. As a CFD on Riisk, ABBV lets you trade on AbbVie's share-price movements without owning the underlying stock — with the ability to go long or short, and with leverage available on margin. AbbVie sits in the Healthcare sector, and is a comparatively defensive, lower-beta stock, with day-to-day moves usually more contained and tied to broader sector and market trends rather than company-specific shocks. AbbVie has an established history of paying a dividend; CFD positions held open through the ex-dividend date receive a corresponding cash adjustment reflecting the dividend, applied automatically on the Riisk platform.

Three layers of drivers shape AbbVie (ABBV) day to day — company-specific news, Healthcare sector trends, and broader macro factors.

AbbVie's share price is shaped most directly by company-specific developments. The factors traders watch most closely are Skyrizi and Rinvoq revenue growth, Humira biosimilar competition and revenue decline, drug pipeline and FDA approval news, and upcoming patent expirations. Quarterly earnings releases are typically the single biggest scheduled catalyst, since they update the market on most of these factors at once.

Beyond company-specific news, ABBV moves with the broader Healthcare sector, which is driven by FDA approval decisions, patent expiration timelines across the sector, and US healthcare policy and drug-pricing debates. Sector sentiment often shows up first in peers such as Eli Lilly and Johnson & Johnson before spreading across the group, so it's worth watching how those names are trading alongside ABBV itself.

Macro factors still matter, though less acutely than for higher-growth names: US interest-rate policy, inflation data and broader economic growth all feed into ABBV, interacting with sector-specific pressure points like upcoming patent expirations, but day-to-day swings are usually smaller than for higher-beta peers.

ABBV rarely trades in isolation. It's a member of the S&P 500 and tends to move with the S&P 500 on days driven by broad market sentiment rather than company news. Within its own sector, Eli Lilly and Johnson & Johnson are the names most worth watching alongside ABBV — a sharp move in one healthcare name often spills into the rest of the group.

ABBV trades on the NYSE during standard US market hours, 9:30–16:00 ET (with pre-market trading from 4:00 ET and after-hours trading until 20:00 ET on many platforms, though liquidity is thinner outside the main session). AbbVie is a comparatively defensive, lower-beta stock, with day-to-day moves usually more contained and tied to broader sector and market trends rather than company-specific shocks, so outside of earnings releases and major healthcare-sector news — particularly updates on Skyrizi and Rinvoq revenue growth — trading conditions tend to be comparatively calm.

Trading AbbVie (ABBV) CFDs on Riisk follows the same process as any other instrument on the platform. 1. Open a Riisk account — register with your email, complete identity verification (KYC) and choose an account type; 2. Fund your account — deposit via the payment methods available through TradeCore; 3. Launch DXTrade — log in on web, desktop or mobile and search for ABBV in the instrument list; 4. Set your trade parameters — choose position size, set a stop-loss and take-profit, and review the live spread; 5. Place and manage the trade — open the position and monitor it from the DXTrade dashboard..

Example (illustrative — confirm live pricing before trading): stock CFD pricing on Riisk typically combines a spread with a small commission per trade, shown on the DXTrade ticket before you confirm. Positions held open overnight may also incur a financing charge, which varies with position size and prevailing interest rates. Because AbbVie pays a dividend, a long CFD position held open through the ex-dividend date receives a cash adjustment equal to the dividend amount; a short position is charged the equivalent. As with other healthcare names, healthcare names can gap on FDA or trial news with little warning, so confirm the live spread before entering around binary events. All figures here are placeholders pending compliance sign-off (FSC Mauritius) — replace with confirmed live values before publishing.